- ChIP assayIn 2009, Mohamed Sabry Hamza et al. applied Santa Cruz Biotechnology PPARgamma antibody to carry out western blot analysis and Ch-IP assays in order to identify the binding sites of PPAR Gramma and RXR in a genome wide manner during adipogenesis (catalog: sc-7196) [ncbi , more ]. In 2008, David J Steger et al. applied Santa Cruz Biotechnology PPARgamma antibody to study the recruitment of DOT1L and the patterning of mono-, di-, and trimethylation of H3K79 under dynamic conditions in human HEK293T cells [ncbi , more ]. In 2006, Jui Pandhare et al. applied Santa Cruz Biotechnology PPARgamma antibody to investigate the binding of PPARgamma to the PPRE in the POX promoter in human colon cancer cell lines HCT116 [ncbi , more ]. In 2005, Mei Nie et al. used Santa Cruz Biotechnology PPARgamma antibody to study the biological function of Peroxisome Proliferator-activated Receptor gamma (PPARgamma) in the regulation of chemokine expression [ncbi , more ].
- immunocytochemistryIn 2004, Claire L Varley et al. employed Santa Cruz Biotechnology PPARgamma antibody to study the role of PPARgamma and EGFR signalling.
Feedback from the author
Clone/Cat no (supplier): E-8 (Santa Cruz); Host: mouse; western blot: we are happy with it; immunoprecipitation: no - use rabbit monoclonal 81B8; IF: no - use rabbit monoclonal 81B8; IHC: we are happy with it [ncbi , more ]. In 2003, Hema J Patel et al. used Santa Cruz Biotechnology PPARgamma antibody to study peroxisome proliferator-activated receptor activation in human airway smooth muscle cells [ncbi , more ].
- immunohistochemistryIn 2009, Minghua Wu et al. utilized Santa Cruz Biotechnology PPARgamma antibody to investigate the role of PPAR-gamma in the regulation of bleomycin induced scleroderma [ncbi , more ]. Li Yang et al. applied Santa Cruz Biotechnology PPARgamma antibody to study the biological function of peroxisome proliferator-activated receptor gamma and ligands [ncbi , more ] in 2003 and Linda Cheung et al. used Santa Cruz Biotechnology PPARgamma antibody to detect PPARgamma in human follicular thyroid tissue (catalog: SC-7273) [ncbi , more ]. In 2002, Ana Rita Marques et al. utilized Santa Cruz Biotechnology PPARgamma antibody to study the expression of PAX8-PPARgamma1 rearrangements in both follicular thyroid carcinomas and adenomas [ncbi , more ].
- immunoprecipitationIn 2009, Jean Philippe Couture et al. applied Santa Cruz Biotechnology PPARgamma antibody to investigate the role of DLK in the regulation of 3T3-L1 adipocyte differentiation [ncbi , more ]. In 2005, Mei Nie et al. used Santa Cruz Biotechnology PPARgamma antibody to study the biological function of Peroxisome Proliferator-activated Receptor gamma (PPARgamma) in the regulation of chemokine expression [ncbi , more ]. In 2004, Joshua P Klopper et al. used Santa Cruz Biotechnology PPARgamma antibody to study the biological function of PPARgamma and RXRgamma in thyroid carcinoma growth [ncbi , more ]. In 2003, Kenji Hata et al. applied Santa Cruz Biotechnology PPARgamma antibody to study the differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis [ncbi , more ].
- western blotIn 2010, Jianhui Ma et al. applied Santa Cruz Biotechnology PPARgamma antibody to carry out western blot analysis in order to investigate the regulation of Notch signaling and cell differentiation by mTOR signaling [ncbi , more ]. Santa Cruz Biotechnology PPARgamma antibody was used in 2009 to investigate the role of DLK in the regulation of 3T3-L1 adipocyte differentiation [ncbi , more ], to perform western blot in order to prove that glutathione peroxidase 3 provides human peroxisome proliferator-activated receptor-gamma with the antioxidant effect [ncbi , more ]and to carry out western blot analysis and Ch-IP assays in order to identify the binding sites of PPAR Gramma and RXR in a genome wide manner during adipogenesis (catalog: sc-7196) [ncbi , more ]. In 2008, A Amoruso et al. used Santa Cruz Biotechnology PPARgamma antibody to evaluate the effects of SP on PPAR-gamma protein expression in monocytes and macrophages (MDMs: monocyte-derived macrophages) from healthy smokers and non-smokers [ncbi , more ]. Jiyoung Park et al. applied Santa Cruz Biotechnology PPARgamma antibody to study the association of glucose-6-phosphate dehydrogenase overexpression with lipid dysregulation and insulin resistance in obesity [ncbi , more ] in 2005 and Lina Sabatino et al. used Santa Cruz Biotechnology PPARgamma antibody to characterize a new peroxisome proliferator-activated receptor gamma isoform (catalog: sc-7273) [ncbi , more ]. Joshua P Klopper et al. used Santa Cruz Biotechnology PPARgamma antibody to study the biological function of PPARgamma and RXRgamma in thyroid carcinoma growth [ncbi , more ] in 2004 and Claire L Varley et al. used Santa Cruz Biotechnology PPARgamma antibody to study the role of PPARgamma and EGFR signalling.
Feedback from the author
Clone/Cat no (supplier): E-8 (Santa Cruz); Host: mouse; western blot: we are happy with it; immunoprecipitation: no - use rabbit monoclonal 81B8; IF: no - use rabbit monoclonal 81B8; IHC: we are happy with it [ncbi , more ]. Santa Cruz Biotechnology PPARgamma antibody was applied in 2003 to illustrate the physiological significance of direct actions of leptin in a given peripheral tissue [ncbi , more ], to study the differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis [ncbi , more ]and to detect PPARgamma in human follicular thyroid carcinoma (catalog: sc-7273) [ncbi , more ]. Taro E Akiyama et al. utilized Santa Cruz Biotechnology PPARgamma antibody to study the effect of RXRalpha on intranuclear distribution of PPAR isoforms [ncbi , more ] in 2002 and Chang Han et al. used Santa Cruz Biotechnology PPARgamma antibody to study the role of 85-kDa cPLA2 in PPAR-mediated gene transcription in human hepatoma cells [ncbi , more ].
- immunohistochemistryIn 2005, Gita Ohlsson et al. utilized Cell Signaling Technology PPARgamma antibody to study the interaction of the loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) with progression of human urothelial carcinomas [ncbi , more ].
- western blotIn 2008, Aruna Jahoor et al. employed Cell Signaling Technology PPARgamma antibody to study the role for peroxisome proliferator-activated receptors in host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer [ncbi , more ]. In 2005, Gita Ohlsson et al. utilized Cell Signaling Technology PPARgamma antibody to study the interaction of the loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) with progression of human urothelial carcinomas [ncbi , more ].
- Jianhui Ma et al. (2010). "Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade".PMID 20038814
- Mohamed Sabry Hamza et al. (2009). "De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis".PMID 19300518
- Jean Philippe Couture et al. (2009). "The mixed-lineage kinase DLK is a key regulator of 3T3-L1 adipocyte differentiation".PMID 19270737
- Minghua Wu et al. (2009). "Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma".PMID 19147827
- Sung Soo Chung et al. (2009). "Glutathione peroxidase 3 mediates the antioxidant effect of peroxisome proliferator-activated receptor gamma in human skeletal muscle cells".PMID 18936159
- David J Steger et al. (2008). "DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells".PMID 18285465
- A Amoruso et al. (2008). "A novel activity for substance P: stimulation of peroxisome proliferator-activated receptor-gamma protein expression in human monocytes and macrophages".PMID 18278062
- Aruna Jahoor et al. (2008). "Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer".PMID 18178738
- Jui Pandhare et al. (2006). "Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms".PMID 16303758
- Jiyoung Park et al. (2005). "Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity".PMID 15923630
- Lina Sabatino et al. (2005). "A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing".PMID 15857827
- Gita Ohlsson et al. (2005). "Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas".PMID 15734831
- Trine Fink et al. (2004). "Induction of adipocyte-like phenotype in human mesenchymal stem cells by hypoxia".PMID 15579652
- Mei Nie et al. (2005). "Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists".PMID 15531761
- Joshua P Klopper et al. (2004). "Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment".PMID 15299084
- Claire L Varley et al. (2004). "Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme".PMID 15054105
- Naveen Babbar et al. (2003). "Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer".PMID 14506281
- Trisha Dwight et al. (2003). "Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors".PMID 12970322
- Jing Ning Huan et al. (2003). "Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance".PMID 12925533
- Li Yang et al. (2003). "Peroxisome proliferator-activated receptor gamma and ligands inhibit surfactant protein B gene expression in the lung".PMID 12829715
- Hema J Patel et al. (2003). "Activation of peroxisome proliferator-activated receptors in human airway smooth muscle cells has a superior anti-inflammatory profile to corticosteroids: relevance for chronic obstructive pulmonary disease therapy".PMID 12594295
- Kenji Hata et al. (2003). "Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis".PMID 12589053
- Linda Cheung et al. (2003). "Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas".PMID 12519876
- Ana Rita Marques et al. (2002). "Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas".PMID 12161538
- Taro E Akiyama et al. (2002). "Selective intranuclear redistribution of PPAR isoforms by RXR alpha".PMID 11923467
- Chang Han et al. (2002). "85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells".PMID 11897617
